Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · IEX Real-Time Price · USD
4.200
+0.370 (9.66%)
At close: Mar 27, 2024, 4:00 PM
4.150
-0.050 (-1.19%)
After-hours: Mar 27, 2024, 7:52 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $222.65 million as of March 28, 2024. Its market cap has increased by 168.90% in one year.
Market Cap
222.65M
Enterprise Value
123.21M
1-Year Change
168.90%
Ranking
Category
Stock Price
$4.20
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $222.65M, a decrease of -57.49%. That is a compound annual growth rate of -29.12%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 26, 2024 | 222.70M | 4.95% |
Mar 25, 2024 | 212.20M | -8.53% |
Mar 22, 2024 | 232.00M | -19.53% |
Mar 21, 2024 | 288.30M | 19.78% |
Mar 20, 2024 | 240.70M | 5.43% |
Mar 19, 2024 | 228.30M | 5.11% |
Mar 18, 2024 | 217.20M | -4.28% |
Mar 15, 2024 | 226.90M | 8.00% |
Mar 14, 2024 | 210.10M | -11.39% |
Mar 13, 2024 | 237.10M | -6.14% |
Mar 12, 2024 | 252.60M | -1.90% |
Mar 11, 2024 | 257.50M | 3.21% |
Mar 8, 2024 | 249.50M | -9.63% |
Mar 7, 2024 | 276.10M | -0.79% |
Mar 6, 2024 | 278.30M | -2.66% |
Mar 5, 2024 | 285.90M | -0.31% |
Mar 4, 2024 | 286.80M | -1.81% |
Mar 1, 2024 | 292.10M | 3.62% |
Feb 29, 2024 | 281.90M | - |
Feb 28, 2024 | 281.90M | -0.14% |
Feb 27, 2024 | 282.30M | 33.22% |
Feb 26, 2024 | 211.90M | -1.62% |
Feb 23, 2024 | 215.40M | 2.52% |
Feb 22, 2024 | 210.10M | 5.10% |
Feb 21, 2024 | 199.90M | -8.13% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Actinium Pharmaceuticals | 225.45M |
Agenus | 224.71M |
Compugen | 224.67M |
Zevra Therapeutics | 224.14M |
G1 Therapeutics | 223.94M |
Vanda Pharmaceuticals | 222.09M |
Omeros | 217.51M |
OptimizeRx | 217.47M |